Institutional investors purchased a net $2.1 million shares of SUPN during the quarter ended June 2014 and now own 52.41% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DISCOVERY GROUP I LLC Bought 278.8 Thousand shares of Supernus Pharmaceuticals ...